Huang, Q.-F. et al. (2018) Biomarkers to assess right heart pressures in recipients of a heart transplant: a proof-of-concept study. Transplantation Direct, 4(5), e346. (doi: 10.1097/TXD.0000000000000783) (PMID:29796417) (PMCID:PMC5959348)
|
Text
163423.pdf - Published Version Available under License Creative Commons Attribution Non-commercial No Derivatives. 545kB |
Abstract
Background: This proof-of-concept study investigated the feasibility of using biomarkers to monitor right heart pressures (RHP) in heart transplanted (HTx) patients. Methods: In 298 patients, we measured 7.6 years post-HTx mean pressures in the right atrium (mRAP) and pulmonary artery (mPAP) and capillaries (mPCWP) along with plasma high-sensitivity troponin T (hsTnT), a marker of cardiomyocyte injury, and the multidimensional urinary classifiers HF1 and HF2, mainly consisting of dysregulated collagen fragments. Results: In multivariable models, mRAP and mPAP increased with hsTnT (per 1-SD, +0.91 and +1.26 mm Hg; P < 0.0001) and with HF2 (+0.42 and +0.62 mm Hg; P ≤ 0.035), but not with HF1. mPCWP increased with hsTnT (+1.16 mm Hg; P < 0.0001), but not with HF1 or HF2. The adjusted odds ratios for having elevated RHP (mRAP, mPAP or mPCWP ≥10, ≥24, ≥17 mm Hg, respectively) were 1.99 for hsTnT and 1.56 for HF2 (P ≤ 0.005). In detecting elevated RHPs, areas under the curve were similar for hsTnT and HF2 (0.63 vs 0.65; P = 0.66). Adding hsTnT continuous or per threshold or HF2 continuous to a basic model including all covariables did not increase diagnostic accuracy (P ≥ 0.11), whereas adding HF2 per optimized threshold increased both the integrated discrimination (+1.92%; P = 0.023) and net reclassification (+30.3%; P = 0.010) improvement. Conclusions: Correlating RHPs with noninvasive biomarkers in HTx patients is feasible. However, further refinement and validation of such biomarkers is required before their clinical application can be considered.
| Item Type: | Articles |
|---|---|
| Additional Information: | The European Union (HEALTH-F7-305507 HOMAGE), the European Research Council (Advanced Researcher Grant 2011-294713-EPLORE and Proof-of-Concept Grant 713601-uPROPHET), the European Research Area Net for Cardiovascular Diseases (JTC2017-046-PROACT), and the Fonds voor Wetenschappelijk Onderzoek Vlaanderen, Ministry of the Flemish Community, Brussels, Belgium (G.0881.13) currently support the Studies Coordinating Centre in Leuven. |
| Status: | Published |
| Refereed: | Yes |
| Glasgow Author(s) Enlighten ID: | Mischak, Professor Harald |
| Authors: | Huang, Q.-F., Trenson, S., Zhang, Z.-Y., Van Keer, J., Van Aelst, L. N. L., Yang, W.-Y., Nkuipou-Kenfack, E., Thijs, L., Wei, F.-F., Mujaj, B., Ciarka, A., Droogné, W., Vanhaecke, J., Janssens, S., Van Cleemput, J., Mischak, H., and Staessen, J. A. |
| College/School: | College of Medical Veterinary and Life Sciences > School of Cardiovascular & Metabolic Health |
| Journal Name: | Transplantation Direct |
| Publisher: | Lippincott, Williams & Wilkins |
| ISSN: | 2373-8731 |
| ISSN (Online): | 2373-8731 |
| Published Online: | 23 April 2018 |
| Copyright Holders: | Copyright © 2018 The Authors |
| First Published: | First published in Transplantation Direct 4(5): e346 |
| Publisher Policy: | Reproduced under a Creative Commons License |
University Staff: Request a correction | Enlighten Editors: Update this record
Funder and Project Information
Funder and Project Information